Transcranial Direct Current to Treat Epilepsy at Home
Launched by STANFORD UNIVERSITY · Mar 13, 2020
Trial Information
Current as of July 23, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Electrical stimulation is a promising new therapy to reduce seizures, but current methods require inserting wires under the skull or into brain. This project will use direct-current electrical stimulation pulses delivered from scalp electrodes to provide stimulation. The goal is to reduce seizures without the need for surgery.
2. PROCEDURES:
2.1. Baseline: Upon signing of consent, subjects will have an initial screening clinic visit with a neurological history and examination. You will record a seizure diary for one month prior to start of stimulation.
2.2. Baseline EEGs: A 2-hour record...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-100, inclusive.
- • Has a clinical diagnosis of epilepsy
- • Has at least 4 countable seizures per month
- • Has not had control with at least 2 anti-seizure medicines
- • Able to maintain a constant medication for duration of the study (rescue meds allowed)
- • Subject or legally authorized representative is able to understand consent and keep a seizure diary in English
- Exclusion Criteria:
- • A disease likely to progress over course of the study
- • Psychogenic non-epileptic seizures
- • Suicide attempt or psychiatric hospitalization past 2 years
- • A skin condition interfering with scalp electrodes or allergy to silver
- • Women will verify not pregnant, and if applicable, have a serum pregnancy test
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Stanford, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials